Elon Musk’s Neuralink has secured approval from the US Food and Drug Administration to begin its first-in-human clinical trials. This remarkable feat signaled a milestone for brain-computer interface technology. Neuralink, the brain-computer interface, will be capable of implanting chips into the human brain, a step that Science and Technology experts deem groundbreaking.
The news of FDA approval, regarding Neuralink, sent Twitter into a state of frenzy and triggered a comparison between Neuralink’s brain chip technology and ChatBot led by Artificial Intelligence. Users expressed both their disbelief and excitement regarding the potential possibilities of Neuralink’s technology. Some were concerned about the safety risks associated with implanting a chip in a human brain, while others were eager to try it out and even offered to be the first person to do it. Unfortunately, Neuralink has not yet opened up for recruitment and stated that it will announce more information soon.
Neuralink is a startup led by venture capitalist and technology entrepreneur Elon Musk. The company is focused on developing brain-computer interface (BCI) technology to improve the human brain’s capabilities. The company was founded in 2016 and has rapidly developed its technology. Neuralink has been experimenting with chips for various animals such as monkeys and pigs before securing approval to experiment on humans.
Elon Musk is a South African-born business magnate, investor, engineer and philanthropist. He is best known as the co-founder and CEO of Tesla Inc. and SpaceX. Musk has made significant contributions to the advancement of renewable energy, revolutionized the auto industry and founded revolutionary business models such as The Boring Company. His venture Neuralink is focused on creating a new neural interface to improve the capabilities of the human brain. With the FDA’s approval, Musk can now be able to progress to his next milestone in developing this futuristic technology.
